No Additional Omapro Trials Needed, FDA Tells ChemGenex In Complete Response Letter
FDA reservations mirror those outlined about need for validated assay test at March 22 ODAC meeting.
FDA reservations mirror those outlined about need for validated assay test at March 22 ODAC meeting.